Melatonin in Alzheimer's Disease: Effect on Disease Progression and Epileptiform Activity. (MADE)

  • STATUS
    Recruiting
  • End date
    Jul 30, 2023
  • participants needed
    60
  • sponsor
    Universitair Ziekenhuis Brussel
Updated on 30 May 2022
cognitive impairment
dementia
alzheimer's disease
mild cognitive impairment
electroencephalogram
Accepts healthy volunteers

Summary

This is a long-term, prospective, observational study to investigate and compare the levels and rhythm of melatonin in patients with AD dementia, mild cognitive impairment due to AD and healthy volunteers. The investigators would like to validate the use of salivary and urine melatonin measurements as an alternative for blood/CSF melatonin. Furthermore, the investigators would like to assess the effects of melatonin levels on cognition by correlating the levels and changes on cognitive tasks over a two year time frame. The investigators will also investigate whether these effects could be due to its anticonvulsive properties.

Description

Melatonin production gets disrupted in AD, as shown in post-mortem pineal glands and CSF of AD patients. CSF melatonin levels are known to significantly drop in patients with Alzheimer's dementia. It is known that CSF melatonin levels are much higher than blood melatonin levels, due to melatonin secretion from the pineal recess directly into the third ventricle. It has never been investigated whether blood melatonin accurately correlates with CSF melatonin in AD, nor whether saliva or urine melatonin levels accurately reflect blood/CSF melatonin in the AD continuum. The investigators want to validate the use of blood, saliva and urine melatonin levels as alternative for CSF melatonin in the AD continuum to pave the way for further use of less invasive collection techniques (blood, saliva, urine instead of CSF) and to possibly study circadian rhythm in a less disrupting, in home environment (saliva, urine).

Furhtermore, melatonin exerts several potential anti-AD properties, including anti-inflammatory, anti-oxidant, tilting APP processing towards the non-amyloidogenic pathway, exerting positive effects on sleep and so on. In vivo studies furthermore point to anticonvulsive and antiepileptic effects of melatonin in a whole range of rodent models. Some evidence exists for a role of melatonin in prevention of epileptic seizures in humans.

The investigators want to investigate influence of melatonin on changes in cognition in a longitudinal way, and investigate influence on (sub)clinical epileptiform activity.

Details
Condition Alzheimer Disease
Treatment MEG+hdEEG+MRI
Clinical Study IdentifierNCT04522960
SponsorUniversitair Ziekenhuis Brussel
Last Modified on30 May 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

Dementia due to AD, according to National Institute on Aging-Alzheimer's Association (NIA-AA) criteria
MCI due to AD, according to NIA-AA criteria
Healthy controls: Age- and gender matched healthy controls

Exclusion Criteria

Patients (AD dementia, MCI)
Age < 18 years old
Pregnancy
Expected death due to illness within 2 years
Pacemaker or other ferrromagnetic material that is not MRI compatible
Other neurodegenerative or cerebrovascular disease
Pattern compatible with NPH (clinically, imaging)
Epilepsy
Multiple sclerosis or other demyelinating disease
Depression, psychosis or other mental disease
Use of anti-epileptic drugs
Alcohol or substance abuse
Korsakoff syndrome
Symptomatic liver disease
Uncontrolled thyroid disorders
Untreated HIV or syphilis
Clinically significant vitamin B12 deficiency
Severe systemic medical illness (eg end-stage cardiac disease, …)
Use of melatonin, agomelatine, or other sleep medications
Night worker
REM sleep behavior disorder, OSAS
Healthy controls
Age < 18 years old
Pregnancy
Pacemaker or other ferromagnetic material that is not MRI compatible
Mild cognitive impairment or dementia of any cause
Epilepsy
Multiple sclerosis or other demyelinating disease
Depression, psychosis or other mental disease
Use of anti-epileptic drugs
Alcohol or substance abuse
Symptomatic liver disease
Uncontrolled thyroid disorders
Untreated HIV or syphilis
Clinically significant vitamin B12 deficiency
Severe systemic medical illness (eg end-stage cardiac disease, …)
Use of melatonin, agomelatine, or other sleep medications
Night worker
REM sleep behavior disorder, OSAS
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note